GO Term | Evidence Code | PMID |
---|---|---|
innate immune response | ||
NAD biosynthesis via nicotinamide riboside salvage pathway | ||
post-transcriptional regulation of gene expression | ||
negative regulation of gene expression | ||
double-strand break repair |
GO Term | Evidence Code | PMID |
---|---|---|
transcription corepressor activity | ||
NAD+ binding | ||
ubiquitin-like protein ligase binding |
DO ID | Disease Name | Source |
---|---|---|
DOID:0080144 | childhood acute lymphocytic leukemia | |
DOID:0110115 | autoimmune lymphoproliferative syndrome type 2A | |
DOID:0110116 | autoimmune lymphoproliferative syndrome type 2B | |
DOID:0110119 | autoimmune lymphoproliferative syndrome type 3 | |
DOID:0110594 | primary ciliary dyskinesia 1 | |
DOID:10283 | prostate cancer | |
DOID:10286 | prostate carcinoma | |
DOID:104 | bacterial infectious disease | |
DOID:1040 | chronic lymphocytic leukemia | |
DOID:10540 | gastric lymphoma |
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
108266415 | ICTPU31382 | ||
431935 | Xenbase:XB-GENE-6251556 | ||
100145202 | Xenbase:XB-GENE-1010331 | ||
109322879 | CROPO10347 | ||
113445446 | PSETE18325 | ||
100550752 | MELGA12227 | ||
103814298 | SERCA06593 | ||
100404232 | CALJA11688 | ||
105589780 | CERAT26655 | ||
102139716 | MACFA27851 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024